MayMag Biologics

Manufacturing infrastructure

End-to-End Manufacturing Capabilities

Two GMP-certified facilities in the Dallas–Fort Worth metroplex, equipped for sterile fill-finish, lyophilisation, peptide synthesis, and large-scale biologics production.

50,000sq ft

Combined facility footprint

12+

ISO-classified cleanrooms

500M+

Units annual capacity

99.9%

Sterility assurance level

What We Can Do For You

Sterile Fill-Finish

Aseptic filling of vials, syringes, and cartridges in ISO 5 environments. Supports aqueous solutions, suspensions, and lyophilised products up to 500,000 units per batch.

  • ISO 5 / Class 100 filling suites
  • Vials: 2 mL – 100 mL
  • Pre-filled syringes: 0.5 mL – 5 mL
  • Automated visual inspection

Lyophilisation

Freeze-drying services for biologics requiring enhanced stability. Multiple lyophiliser units with validated cycles for peptides, proteins, and small molecules.

  • 4 production-scale lyophilisers
  • Shelf area: up to 40 m²
  • Validated cycle development
  • Residual moisture testing

Peptide Synthesis

Solid-phase peptide synthesis (SPPS) at milligram to kilogram scale. Fmoc and Boc chemistry with full analytical characterisation and GMP batch records.

  • Fmoc / Boc SPPS
  • Scale: 1 g – 5 kg per batch
  • HPLC purity ≥ 98%
  • Full MS characterisation

Quality Control Laboratory

In-house QC laboratory with HPLC, LC-MS, Karl Fischer titration, endotoxin testing, and full microbiological suite for release and stability testing.

  • USP-compliant methods
  • Endotoxin (LAL) testing
  • Sterility testing suite
  • Stability chambers (ICH zones)

Cold Chain Management

Validated cold chain infrastructure from manufacturing through distribution. Dedicated 2–8°C and -20°C storage with 24/7 temperature monitoring and alarm systems.

  • 2–8°C refrigerated storage
  • -20°C and -80°C freezer banks
  • Qualified shipping containers
  • Real-time temperature logging

Autoinjector & Pen Assembly

Assembly and packaging of autoinjector devices, insulin pens, and prefilled delivery systems. Supports both proprietary and licensed device platforms.

  • Insulin pen assembly
  • Autoinjector integration
  • Cartridge filling
  • Device functionality testing

Ready to discuss your manufacturing needs?

Our technical team can assess feasibility, timelines, and capacity for your programme.

Request a Capabilities Review